Ontology highlight
ABSTRACT:
SUBMITTER: Monzon JG
PROVIDER: S-EPMC3299555 | biostudies-other | 2012
REPOSITORIES: biostudies-other
OncoTargets and therapy 20120305
In the last year, the armamentarium of melanoma therapeutics has radically changed. Recent discoveries in melanoma biology and immunology have led to novel therapeutics targeting known oncogenes and immunotherapeutic antibodies. Phase III clinical trials of these agents have reported measurable and meaningful benefits to patients with metastatic disease. In this article, we review recent findings and discuss their significance in melanoma therapy. As our understanding of melanoma biology grows, ...[more]